These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 9569462

  • 1. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract] [Full Text] [Related]

  • 2. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force.
    Treleaven J, Gennery A, Marsh J, Norfolk D, Page L, Parker A, Saran F, Thurston J, Webb D.
    Br J Haematol; 2011 Jan; 152(1):35-51. PubMed ID: 21083660
    [No Abstract] [Full Text] [Related]

  • 3. Transfusion medicine 1994.
    Pineda A, Korbling M, Rock GA.
    Rev Invest Clin; 1994 Apr; Suppl():101-15. PubMed ID: 7886293
    [No Abstract] [Full Text] [Related]

  • 4. The use of leukocyte-reduced blood components.
    Miller JP, Mintz PD.
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):69-90. PubMed ID: 7737945
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leukocyte-reduced blood components in transfusion medicine. Current indications and prospects for the future.
    Klapper EB, Goldfinger D.
    Clin Lab Med; 1992 Dec; 12(4):711-21. PubMed ID: 1286560
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML, Ludlam CA.
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [Abstract] [Full Text] [Related]

  • 10. Guidelines for administration of blood products: transfusion of infants and neonates. British Committee for Standards in Haematology Blood Transfusion Task Force.
    Voak D, Cann R, Finney RD, Fraser ID, Mitchell R, Murphy MF, Napier JA, Phillips P, Rejman AJ, Waters AH.
    Transfus Med; 1994 Mar; 4(1):63-9. PubMed ID: 8012495
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quality requirements and quality assurance of leukocyte-depleted blood components.
    Myllylä G.
    Curr Stud Hematol Blood Transfus; 1994 Mar; (60):111-22. PubMed ID: 8088164
    [No Abstract] [Full Text] [Related]

  • 13. Perspective on Nordic views on selective/universal leukodepletion.
    Flesland O.
    Transfus Sci; 1998 Dec; 19(4):355-7. PubMed ID: 10351154
    [No Abstract] [Full Text] [Related]

  • 14. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
    García Gala JM, Ramírez Páyer A, Rayón C, Rodríguez Vicente P, Rosón C, Blanco C.
    Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transfusion of blood components to infants under four months: review and guidelines.
    O'Riordan JM, Fitzgerald J, Smith OP, Bonnar J, Gorman WA, National Blood Users Group.
    Ir Med J; 2007 Jun; 100(6):suppl 1-24 following 496. PubMed ID: 17668683
    [No Abstract] [Full Text] [Related]

  • 19. International views on universal leucodepletion: the perspective in NBS, Ireland.
    Murphy W.
    Transfus Sci; 1998 Dec; 19(4):349-50. PubMed ID: 10351151
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.